项目编号：DT-BD-20200412-011
Project Number: DT-BD-20200412-011
项目内容：欧洲药企寻找免疫学（immunology）和神经病学（neurology）项目。专注于免疫学（自身免疫性疾病，而非免疫肿瘤学）和神经病学（癫痫、帕金森氏症和神经退行性疾病）领域，对神经系统疾病的基因疗法（和细胞疗法）感兴趣，也对蛋白质降解等新形式感兴趣。
Request: focuses on the area of immunology (autoimmune diseases, not immuno oncology ), and neurology (epilepsy, Parkinson’s and neurodegeneration), interested in gene therapy (and cell therapy) for neurological disorders, also in the new modality of protein degradation.
目标领域：专注于免疫学（自身免疫性疾病，而非免疫肿瘤学）和神经病学（癫痫、帕金森氏症和神经退行性疾病）领域
Target area: focuses on the area of immunology (autoimmune diseases, not immuno oncology ), and neurology (epilepsy, Parkinson’s and neurodegeneration)
目标阶段：全部，只要创新程度高
Target stage: all stages, as long as innovative
药物类别：小分子药、生物药、细胞疗法、基因疗法，等等
Drug category: small molecule drugs, biological drugs, cell therapy, gene therapy
目标权益：最好是全球权益
Target right: Global rights ideally
如果您对该合作机会感兴趣，欢迎与我们联系！我们将与您详细探讨。谢谢！
If you are interested in introducing this collaboration opportunity, please contact us. We will discuss with you in details. Thank you very much!
联系人 (Contact)：Will
电话 (Mobile)：13564569657
微信 (Wechat)：27674131
邮箱 (E-mail)：BD@drugtimes.cn
邮件主题请注明：项目编号：DT-BD-20200412-011
In the e-mail subject, please include “Project Number: DT-BD-20200412-011”
发布者：DrugTimes001，转载请首先联系contact@drugtimes.cn获得授权
为好文打赏 支持药时代 共创新未来！ 
